Rating History for Recursion Pharmaceuticals (RXRX ) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for RXRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/17/2026 Sean Laaman Maintain Equalweight
(N/A)		 5.30
(5.50)		  
 		   Details